Seriously? With healthcare reform, the US government is going to dole out almost $300k per year for a chronic treatment and not a cure? We are still 2-3 years away to find out. So you don't mind locking up your money til then. Oh and by the way, during that time the HCV sales will get nipped away as each one of its competitors launches new HCV drugs. Gilead already submitted its med earlier this month. And unlike CF, when patients with hep C retain levels below 25iu/ml 6 months after cessation of treatment, they are considered cured. The reimbursement for this "cure" is ~$50k. So you really think the reimbursement for a chronic treatment will be 6X?